sivelestat has been researched along with methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albeck, A; Khalfin, B; Lichtenstein, A; Nathan, I | 1 |
| Chen, Y; Cui, Y; Deng, Y; Fu, Q; Jiang, P; Li, J; Lin, J; Liu, Y; Meng, Q; Sun, Y; Wang, L; Wang, M; Xu, H; Ye, B; Zhang, M; Zhang, S; Zhang, T; Zhao, X | 1 |
2 other study(ies) available for sivelestat and methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone
| Article | Year |
|---|---|
Targeting Necrosis: Elastase-like Protease Inhibitors Curtail Necrotic Cell Death Both
Topics: Animals; Brain Injuries, Traumatic; Cell Death; Chemical and Drug Induced Liver Injury; High-Throughput Screening Assays; Humans; Mice, Inbred BALB C; Mice, Inbred C57BL; Myocardial Infarction; Necroptosis; Necrosis; Pancreatic Elastase; Protease Inhibitors; RNA, Small Interfering; U937 Cells | 2021 |
Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and In Vivo Biological Evaluation for Acute Lung Injury.
Topics: Acute Lung Injury; Animals; Bleomycin; Cell Line; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Humans; Leukocyte Elastase; Male; Mice; Mice, Inbred C57BL; Peptides, Cyclic; Respiratory Distress Syndrome; Serine Proteinase Inhibitors | 2022 |